Heart stent showdown: one branch or two?
NCT ID NCT00376571
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the best way to use drug-eluting stents (tiny mesh tubes that release medication) in patients with coronary artery disease where the blockage is at a fork (bifurcation). 413 patients were randomly assigned to get stents in both branches of the fork or only in the main branch, with optional treatment of the side branch. The goal was to see which approach reduces the risk of heart-related death, heart attack, stent clotting, or the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
drug-eluting stent
What this could lead to
If successful, this could help doctors choose the safest and most effective stenting strategy for patients with blocked arteries at a fork (bifurcation).
What could go wrong
This is a completed Phase 4 trial with 413 patients, so results are already known. The findings may not apply to all types of blockages or newer stents.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Skejby Hospital, University of Aarhus
Aarhus, 8200, Denmark